Friday, May 27, 2022 Daily Archives

Time to competency must be reduced to get to market faster, says Virtuosi

by

Talent shortages and training issues were identified at Advanced Therapies 2022  as one of the challenges restricting ATMPs pathway to commercialization.   The difficulty to recruit highly-skilled individuals in the advanced therapy space has been heavily documented, and companies such as Lonza, SwedenBIO, and MilliporeSigma have expressed their talent shortage concerns to this publication at different times over the past couple of years. With its high cost and potential to affect time-to-market, it was no surprise that recruitment was at the forefront of…

May 27, 2022

CEPI’s 100-day vaccine mission takes aim at future pandemics

by

Every single step of the vaccine process needs shortening says CEPI, which is developing a strategy to produce safe and effective vaccines against future threats in just 100 days. Face-to-face events are well underway, and BioProcess Insider headed to BPI Europe in Vienna, Austria where Anna Särnefält, CMC lead at the Coalition for Epidemic Preparedness Innovations (CEPI), said the key to responding to epidemics and pandemics is preparedness. The 100 Days Mission is a project that aims to  produce safe…

May 27, 2022

Bavarian Nordic to respond to monkeypox threat with vaccine supply

by

Bavarian Nordic will supply its smallpox vaccine Imvanex to at least two countries as cases of monkeypox surge in Europe and elsewhere. The surge of cases of monkeypox outside west and central Africa have alarmed health authorities over the past few weeks. While some commentators claim the outbreak is nothing to be too concerned about, some governments have looked to secure vaccinations in order to mitigate against a potential epidemic. There is no official vaccine for monkeypox in Europe, but…

May 27, 2022

Lilly lays out $2.1bn for two plants in Indiana

by

Eli Lilly is investing $2.1 billion to build two manufacturing facilities in Indiana to expand its services for active ingredients and therapeutic modalities. Lilly will construct the two manufacturing sites at LEAP Lebanon Innovation and Research District in Boone County, Indiana and said the decision to expand its network reflects the firm’s commitment to strengthening its portfolio. “More than 146 years after our founding, Lilly remains committed to investing and innovating in Indiana,” said David Ricks, Lilly’s CEO. “These new sites will add capacity in…

May 27, 2022